Skip to main content
NCD 190.22 · version 1 · Laboratory NCD

NCD 190.22: Thyroid Testing

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database NCDs: API snapshot September 27, 2026 (effective September 20, 2026); Lab NCD code lists: October 2026 (effective October 1, 2026). Next CMS release: weekly, every Thursday for the Medicare Coverage Database NCDs; January 1, 2027 (quarterly update) for the Lab NCD code lists.

Medicare Coverage Database NCDs: the loaded version is API snapshot September 27, 2026, and the CMS schedule called for a newer one from October 1, 2026. Verify figures against the current CMS publication until this reference is rebuilt; pages built on it are withdrawn from search indexing until then.

Key facts for NCD 190.22

Benefit category
Diagnostic Laboratory Tests
Effective date
11/25/2002
Implemented 01/01/2003
Transmittal
Transmittal 17
Versions published
1
Manual section
190
Pathology and Laboratory, NCD Manual (Pub. 100-03) chapter 1 part 3
Lab edit list
1,406 covered ICD-10
233 non-covered

TL;DR

NCD 190.22 sets Medicare's national policy for thyroid testing under the benefit category "Diagnostic Laboratory Tests", effective 11/25/2002 and implemented 01/01/2003. Thyroid function tests are used to define hyper function, euthyroidism, or hypofunction of thyroid disease. Thyroid testing may be reasonable and necessary to: As a laboratory NCD it carries a national ICD-10 edit list: 1,406 diagnosis codes support medical necessity and 233 are denied, applied automatically by every Medicare contractor to 4 procedure codes.

Item or service described

Thyroid function studies are used to delineate the presence or absence of hormonal abnormalities of the thyroid and pituitary glands. These abnormalities may be either primary or secondary and often but not always accompany clinically defined signs and symptoms indicative of thyroid dysfunction.

Laboratory evaluation of thyroid function has become more scientifically defined. Tests can be done with increased specificity, thereby reducing the number of tests needed to diagnose and follow treatment of most thyroid disease. Measurements of serum sensitive thyroid-stimulating hormone (TSH) levels, complemented by determination of thyroid hormone levels [free thyroxine (fT-4) or total thyroxine (T4) with Triiodothyronine (T3) uptake] are used for diagnosis and follow-up of patients with thyroid disorders.

Additional tests may be necessary to evaluate certain complex diagnostic problems or on hospitalized patients, where many circumstances can skew tests results. When a test for total thyroxine (total T4 or T4 radioimmunoassay) or T3 uptake is performed, calculation of the free thyroxine index (FTI) is useful to correct for abnormal results for either total T4 or T3 uptake due to protein binding effects.

Indications and limitations of coverage

Indications

Thyroid function tests are used to define hyper function, euthyroidism, or hypofunction of thyroid disease. Thyroid testing may be reasonable and necessary to:

• Distinguish between primary and secondary hypothyroidism;

• Confirm or rule out primary hypothyroidism;

• Monitor thyroid hormone levels (for example, patients with goiter, thyroid nodules, or thyroid cancer);

• Monitor drug therapy in patients with primary hypothyroidism;

• Confirm or rule out primary hyperthyroidism; and

• Monitor therapy in patients with hyperthyroidism.

Thyroid function testing may be medically necessary in patients with disease or neoplasm of the thyroid and other endocrine glands. Thyroid function testing may also be medically necessary in patients with metabolic disorders; malnutrition; hyperlipidemia; certain types of anemia; psychosis and non-psychotic personality disorders; unexplained depression; ophthalmologic disorders; various cardiac arrhythmias; disorders of menstruation; skin conditions; myalgias; and a wide array of signs and symptoms, including alterations in consciousness; malaise; hypothermia; symptoms of the nervous and musculoskeletal system; skin and integumentary system; nutrition and metabolism; cardiovascular; and gastrointestinal system.

It may be medically necessary to do follow-up thyroid testing in patients with a personal history of malignant neoplasm of the endocrine system and in patients on long-term thyroid drug therapy.

Limitations

Testing may be covered up to two times a year in clinically stable patients; more frequent testing may be reasonable and necessary for patients whose thyroid therapy has been altered or in whom symptoms or signs of hyperthyroidism or hypothyroidism are noted.

Note: Scroll down for links to the quarterly Covered Code Lists (including narrative).

Text reproduced from the CMS Medicare Coverage Database record for NCD 190.22 version 1. View the original on cms.gov.

Laboratory NCD code lists (October 2026)

Medicare contractors apply this NCD through a national edit: the procedure codes below are paid only when the claim carries a covered diagnosis. The October 2026 list holds 1,406 covered and 233 non-covered ICD-10-CM codes; any code not on the list does not support medical necessity.

4 procedure codes are edited against this NCD's diagnosis list. CPT codes are shown as numbers only; descriptors are licensed by the AMA.

Procedure codes subject to NCD 190.22
CodeCode set
84436CPT (descriptor licensed by AMA)
84439CPT (descriptor licensed by AMA)
84443CPT (descriptor licensed by AMA)
84479CPT (descriptor licensed by AMA)

What Medicare pays for these tests: 4 of the 4 codes carry a national payment amount on the October 2026 Clinical Laboratory Fee Schedule, from $6.47 to $16.80, with no deductible or coinsurance. QW marks the CLIA-waived variant of a test.

Clinical Laboratory Fee Schedule amounts for the codes NCD 190.22 edits, October 2026
CodeCLFS amountWith QWPricing
84436$6.87—national payment amount
84439$9.02—national payment amount
84443$16.80$16.80national payment amount
84479$6.47—national payment amount
Source: CMS Clinical Laboratory Fee Schedule 26CLABQ4. Every code range and the October changes are on the Clinical Laboratory Fee Schedule page.

The first 40 of 1,406 covered diagnosis codes, with FY2027 ICD-10-CM descriptions. A claim with any covered code on the line supports medical necessity under the national edit.

Covered ICD-10-CM codes for NCD 190.22 (sample)
ICD-10-CMDescriptionEffective
A18.81Tuberculosis of thyroid gland2015-10-01
C56.1Malignant neoplasm of right ovary2015-10-01
C56.2Malignant neoplasm of left ovary2015-10-01
C56.3Malignant neoplasm of bilateral ovaries2021-10-01
C56.9Malignant neoplasm of unspecified ovary2015-10-01
C73Malignant neoplasm of thyroid gland2015-10-01
C75.8Malignant neoplasm with pluriglandular involvement, unspecified2015-10-01
C79.63Secondary malignant neoplasm of bilateral ovaries2021-10-01
C79.89Secondary malignant neoplasm of other specified sites2015-10-01
C79.9Secondary malignant neoplasm of unspecified site2015-10-01
D09.3Carcinoma in situ of thyroid and other endocrine glands2015-10-01
D09.8Carcinoma in situ of other specified sites2015-10-01
D27.0Benign neoplasm of right ovary2015-10-01
D27.1Benign neoplasm of left ovary2015-10-01
D27.9Benign neoplasm of unspecified ovary2015-10-01
D34Benign neoplasm of thyroid gland2015-10-01
D35.2Benign neoplasm of pituitary gland2015-10-01
D35.3Benign neoplasm of craniopharyngeal duct2015-10-01
D44.0Neoplasm of uncertain behavior of thyroid gland2015-10-01
D44.2Neoplasm of uncertain behavior of parathyroid gland2015-10-01
D44.9Neoplasm of uncertain behavior of unspecified endocrine gland2015-10-01
D49.7Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system2015-10-01
D51.0Vitamin B12 deficiency anemia due to intrinsic factor deficiency2015-10-01
D53.9Nutritional anemia, unspecified2015-10-01
D59.0Drug-induced autoimmune hemolytic anemia2015-10-01
D59.10Autoimmune hemolytic anemia, unspecified2020-10-01
D59.11Warm autoimmune hemolytic anemia2020-10-01
D59.12Cold autoimmune hemolytic anemia2020-10-01
D59.13Mixed type autoimmune hemolytic anemia2020-10-01
D59.19Other autoimmune hemolytic anemia2020-10-01
D64.89Other specified anemias2016-10-01
D64.9Anemia, unspecified2015-10-01
D89.82Autoimmune lymphoproliferative syndrome [ALPS]2015-10-01
D89.831Cytokine release syndrome, grade 12020-10-01
D89.832Cytokine release syndrome, grade 22020-10-01
D89.833Cytokine release syndrome, grade 32020-10-01
D89.834Cytokine release syndrome, grade 42020-10-01
D89.835Cytokine release syndrome, grade 52020-10-01
D89.839Cytokine release syndrome, grade unspecified2020-10-01
D89.84IgG4-related disease2023-10-01

233 diagnosis codes deny automatically under this NCD; the first 20 are shown.

Non-covered ICD-10-CM codes for NCD 190.22 (sample)
ICD-10-CMDescription
R99Ill-defined and unknown cause of mortality
Z00.00Encounter for general adult medical examination without abnormal findings
Z00.01Encounter for general adult medical examination with abnormal findings
Z00.110Health examination for newborn under 8 days old
Z00.111Health examination for newborn 8 to 28 days old
Z00.121Encounter for routine child health examination with abnormal findings
Z00.129Encounter for routine child health examination without abnormal findings
Z00.5Encounter for examination of potential donor of organ and tissue
Z00.6Encounter for examination for normal comparison and control in clinical research program
Z00.70Encounter for examination for period of delayed growth in childhood without abnormal findings
Z00.71Encounter for examination for period of delayed growth in childhood with abnormal findings
Z00.8Encounter for other general examination
Z02.0Encounter for examination for admission to educational institution
Z02.1Encounter for pre-employment examination
Z02.2Encounter for examination for admission to residential institution
Z02.3Encounter for examination for recruitment to armed forces
Z02.4Encounter for examination for driving license
Z02.5Encounter for examination for participation in sport
Z02.6Encounter for examination for insurance purposes
Z02.71Encounter for disability determination

Changed in October 2026

The October 2026 lab NCD release changed this NCD's ICD-10-CM list: 3 codes added and 1 code removed against January 2026. CMS marked 3 rows of the list as changed in this release. A removed code stops counting for the edit after its term date; where the FY2027 ICD-10-CM update deleted the code, the replacement codes listed below are the ones to report from October 1, 2026.

ICD-10-CM codes added to NCD 190.22 in October 2026
ICD-10-CMFY2027 descriptionResult
I49.81Brugada syndromecovered
I49.82Ventricular bigeminycovered
I49.89Other specified cardiac arrhythmias not elsewhere classifiedcovered
ICD-10-CM codes removed from NCD 190.22 in October 2026
ICD-10-CMDescriptionWasWhy
I49.8Other specified cardiac arrhythmiascovereddeleted from ICD-10-CM; replaced by G90.A, I49.81, I49.82, I49.89

Codes on this NCD's list by release: October 2025: 1,620 · January 2026: 1,637 · October 2026: 1,639. Every change across the 23 laboratory NCDs is in the lab NCD code-list change report.

Local policies that build on this NCD

2 active Local Coverage Determinations cite NCD 190.22 among their related national policies. An LCD may not conflict with the national determination; read it for the contractor's documentation and coding detail in that jurisdiction.

How MACs bill NCD 190.22

A National Coverage Determination states the policy; the Medicare Administrative Contractors publish the articles that turn it into claim edits. 1 current article in the Medicare Coverage Database names NCD 190.22, 1 of them with a covered ICD-10-CM list, from 1 contractor. The lists can differ by contractor even though the NCD is national, because each MAC codes the policy for its own claims system; check the article of the contractor that processes the claim.

Contractors with articles that implement NCD 190.22
ContractorArticles
Wellpoint FederalA58656

A58656: Billing and Coding: Thyroid Nodule Molecular Testing

Billing and Coding, effective 2026-04-01 · Wellpoint Federal (06101, 06102, 06201, 06202, 06301, 06302, 13101, 13102, 13201, 13202, 13282, 13292, 14111, 14112, 14211, 14212, 14311, 14312, 14411, 14412, 14511, 14512) · CMS record

10 covered ICD-10-CM codes; 4 procedure codes: 0018U, 0026U, 81546, 81599. Local policy: L38968 Thyroid Nodule Molecular Testing. Check a diagnosis for 0018U.

First covered codes: D44.0 Neoplasm of uncertain behavior of thyroid gland; D44.9 Neoplasm of uncertain behavior of unspecified endocrine gland; E01.0 Iodine-deficiency related diffuse (endemic) goiter; E01.1 Iodine-deficiency related multinodular (endemic) goiter; E01.2 Iodine-deficiency related (endemic) goiter, unspecified; E04.0 Nontoxic diffuse goiter; …

Revision history

07/2004 - Published NCD in the NCD Manual without change to narrative contained in PM AB-02-110. Coding guidance now published in Medicare Lab NCD Manual. Effective and Implementation dates NA. ( TN 17 ) (CR 2130)

07/2002 - Implemented NCD. Effective date 11/25/02. Implementation date 1/01/03. ( TN AB-02-110 ) (CR 2130)

How this NCD shows up on remittances

A service denied under a National Coverage Determination returns CARC 50 (not deemed medically necessary) with remark N386 (decision based on an NCD); a denial citing a local policy instead carries N115. Because NCDs bind nationally, the appeal path is documentation that the patient meets the indications above, not a contractor-policy argument.

For teams evaluating QuickIntell software

Evaluate a coverage-review workflow around NCD 190.22

Explore QuickAuth for requirement checks, documentation preparation and status tracking with staff oversight. Bring the policy-review steps your team repeats to a scoped evaluation, and confirm plan-specific requirements and supported actions. Use QuickRCM to evaluate the separate claim and denial workflow; a published NCD is not an authorization or payment guarantee.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — NCD 190.22

What does NCD 190.22 cover?

Thyroid function tests are used to define hyper function, euthyroidism, or hypofunction of thyroid disease. Thyroid testing may be reasonable and necessary to: The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database.

When did NCD 190.22 take effect?

The current version (1) is effective 11/25/2002, implemented 01/01/2003, published in transmittal 17. This is the only published version.

Does a Local Coverage Determination override NCD 190.22?

No. A National Coverage Determination binds all Medicare Administrative Contractors; an LCD can only address services or circumstances the NCD leaves open. Claims denied under this NCD typically return CARC 50 with remark N386 (NCD) rather than N115 (LCD).

Which diagnosis codes are covered under NCD 190.22?

The October 2026 laboratory NCD edit list contains 1,406 ICD-10-CM codes that support thyroid testing (for example A18.81 Tuberculosis of thyroid gland; C56.1 Malignant neoplasm of right ovary; C56.2 Malignant neoplasm of left ovary) and 233 codes that deny. The list applies to 84436, 84439, 84443, 84479.

How often does the lab NCD code list for 190.22 change?

CMS updates the laboratory NCD edit module quarterly, with the October release carrying the annual ICD-10-CM code changes. Codes added or deleted mid-year appear in the quarterly change spreadsheets on the Lab NCDs page.

CMS guidance

Medicare Learning Network publications that CMS issues on this topic, cited by ICN and publication date:

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page reproduces the CMS National Coverage Determination text and, for laboratory NCDs, the CMS ICD-10 edit lists, as an operational reference. Coverage decisions depend on the full policy, the claim and the contractor; nothing here is legal, clinical or billing advice. CPT codes are shown as numbers only; CPT descriptors are copyright AMA.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.